课题基金 / 基金详情

Interferon Alpha Regulation of Murine Gammaherpesvirus Latency

Interferon Alpha Regulation of Murine Gammaherpesvirus Latency
干扰素α对鼠丙型疱疹病毒潜伏期的调节
批准号:
7986162
负责人:
Erik S Barton
金额:
$9.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-15 至 2010-12-31

项目摘要

项目成果

Erik S Barton的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):I型干扰素(IFN)细胞因子家族是抵御病毒感染的第一道天然防线。缺乏IFN受体(IFNAR1-/-)的小鼠表现出高水平的病毒复制和更高的死亡率,表明IFN在宿主对病毒感染的反应中起关键作用。然而,目前流行的IFN功能模型认为,这些细胞因子仅在急性感染期间发挥作用,一旦适应性免疫反应抑制了病毒复制,它们就不再起作用了。对于慢性或潜伏性感染中IFN的潜在功能所知相对较少。我们意外地发现,IFN在体内潜伏期阻止小鼠疱疹病毒68 (MHV68)的再激活。MHV68是小鼠的一种天然病原体,在遗传和病理上与人类相似。-疱疹病毒eb病毒和卡波西肉瘤疱疹病毒。IFN在MHV68潜伏期的作用不需要最具特征的IFN刺激的抗病毒基因,这促使我们考虑一种新的机制。事实上,我们的初步数据表明,在潜伏感染的B细胞中,IFN通过细胞干扰素调节因子(IRFs)与病毒启动子的结合,直接调节MHV68潜伏基因的表达。这提示了一个有趣的假设,即-疱疹病毒已经进化到将其基因表达通路与IFN信号通路整合,从而选择宿主抗病毒系统来促进免疫功能低下期间的策略性再激活时机。本研究利用可处理的MHV68系统来鉴定IFN在体内调节病毒潜伏基因表达和再激活中的生理作用。提出了三个特定目的:(i)验证IFN通过在潜伏期直接作用于感染细胞来调节MHV68感染的假设;(ii)鉴定控制复制、基因表达和再激活的干扰素调节的病毒启动子元件;(iii)确定irf调节潜伏病毒基因表达和再激活的机制。这项研究将对了解慢性感染过程中IFN的功能具有广泛意义,并将导致宿主抗病毒途径的鉴定,这些途径可能被证明与致癌人类疱疹病毒的控制有关。
英文摘要
DESCRIPTION (provided by applicant): The type I interferon (IFN) cytokine family comprises the first line of innate defense against virus infections. Mice lacking the IFN receptor (IFNAR1-/-) display high-level virus replication and increased mortality, demonstrating a critical role for IFN in host response to virus infection. However, prevailing models of IFN function assume that these cytokines function solely during acute infection and are dispensable once the adaptive immune response has silenced viral replication. Relatively little is known about potential functions of IFN during chronic or latent infection. We found unexpectedly that IFN prevents reactivation of murine -herpesvirus 68 (MHV68) during latency in vivo. MHV68 is a natural pathogen of mice and displays genetic and pathologic similarities to the human ?-herpesviruses Epstein-Barr virus and Kaposi Sarcoma herpesvirus. The effects of IFN during MHV68 latency did not require the most well characterized IFN-stimulated antiviral genes, which prompted us to consider a novel mechanism. Indeed, our preliminary data show that IFN directly regulates MHV68 latent gene expression via the binding of cellular interferon regulatory factors (IRFs) to viral promoters in latently-infected B cells. This suggests the intriguing hypothesis that -herpesviruses have evolved to integrate their gene expression circuitry with IFN signaling pathways, thereby co-opting a host antiviral system to promote strategic timing of reactivation during periods of immunocompromise. The proposed research uses the tractable MHV68 system to identify the physiologic roles of IFN in regulating viral latent gene expression and reactivation in vivo. Three Specific Aims are proposed to: (i) test the hypothesis that IFN regulates MHV68 infection by acting directly on the infected cell during latency; (ii) identify interferon-regulated viral promoter elements that control replication, gene expression, and reactivation and (iii) define the mechanism by which IRFs regulate latent viral gene expression and reactivation. This research will have broad significance for understanding IFN function during chronic infections and will lead to the identification of host antiviral pathways that may prove relevant for control of oncogenic human??-herpesviruses. PUBLIC HEALTH RELEVANCE: The proposed studies will enhance an understanding of mechanisms by which type I interferons function in chronic infections in humans. Furthermore, as MHV68 is closely related to the human pathogens Epstein-Barr virus and Kaposi sarcoma-associated herpesvirus, these studies will provide new insights into potential therapeutic targets for treatment of cancers arising during latent gammaherpesvirus infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interferon Alpha Regulation of Murine Gammaherpesvirus Latency
Interferon Alpha Regulation of Murine Gammaherpesvirus Latency
Interferon Alpha Regulation of Murine Gammaherpesvirus Latency
Interferon Alpha Regulation of Murine Gammaherpesvirus Latency
海外基金